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Pulmonary Tuberculosis Treatment Outcomes in HIV
Infected Patients on Antiretroviral Therapy
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Background: Tuberculosis (TB) is the most common opportunistic
infection (OI) in HIV-infected patients. There are effective regimes
for HIV and TB infection, but the concomitant treatment is diffi-
cult due to adverse effects, drug interaction, and worsening con-
dition. Not all anti-TB drugs are available in developing countries.
This study describes treatment outcomes of pulmonary TB in HIV-
infected patients on antiretroviral therapy (ART).
Materials and Methods: This retrospective study was done at Bam-
rasnaradura Institute, Bangkok. The study was conducted among
TB and HIV co-infected patients, aged 15 years and older, who
received both anti-TB and ART (NNRTI-base). The patients were
admitted in this institute from January 1, 2003 to December 31,
2004.
Results: Sixty-five patients (47 male) with a median age of 32 years
old (range 20-58) was entered into the study. When the TB was
diagnosed, the median CD4 count was 33 cells/ul (range 2-342).
Fifty patients (76.92%) received standard anti-TB (HRZE) regimes
for at least 2 months in the initial phase and fifteen patients
(23.08%) did not receive regimes as above. ART was initiated at
a median of 12 weeks (range 0-52) of TB treatment. Eight patients
(12.3%) had already received ART before the TB diagnosis. Forty-
three (66.1%) and 22 (33.9%) patients received nevirapine (NVP)
and efervirenz (EFV) based regimes, respectively. Thirty-six pa-
tients (55.4%) received NVP and rifampicin (RFP) concurrently, and
the median of overlapping day was 115 (range 5-394). Drug tox-
icity was observed in 26 patients (40%). There was no significant
association between drug toxicity and concurrent use of NVP and
RFP. Five patients (7.7%) had immune reconstitution syndrome and
4 patients (6.2%) had OI after ART. Thirty-three patients (50.8%)
were clinically cured, 20 (30.8%) were cured, 5 (7.7%) were trans-
ferred out, 3(4.6%) had treatment interrupted, 3 (4.6%) died and 1
patient had treatment. There were no associations between treat-
ment outcomes and anti-TB regimes, ART regimes and concurrent
use of NVP and RFP, but initiating ART before or during TB treat-
ment was significantly associated with favorable treatment out-
comes.
Conclusions: Initiation of ART in the early course of HIV infection,
before TB infection, yields a favorable pulmonary TB treatment
outcome. NVP-based ART is an option for HIV-infected patients re-
ceiving RFP. This result is expected to be beneficial for medical
personals involved in HIV patients especially in developing coun-
tries.
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Introduction: The current estimate of the burden of typhoid fever
in Africa is based on population-based studies from Egypt and
South Africa and no estimate is available for invasive non-Typhi
Salmonella (NTS). To gain initial insights into the epidemiology of
invasive salmonellosis in East Africa, we studied febrile admissions
at three hospitals in northern Tanzania.
Methods: We enrolled consecutive febrile patients aged 2 months
to 13 years at Teule District Hospital (TDH), Muheza, and at Kili-
manjaro Christian Medical Centre (KCMC), Moshi, and febrile pa-
tients aged 13 years and above at KCMC and Mawenzi Regional
Hospital (MRH), Moshi. All patients received a standardized clin-
ical history and physical examination, aerobic blood culture, and
HIV antibody testing.
Results: Of 3,664 children admitted to TDH, 319 (8.7%) were bac-
teremic of whom 23 (16%) were HIV antibody-positive on a sin-
gle test, 161(50.5%) had NTS and 9 (2.8%) had S. Typhi blood-
stream infection. Of 33 bacteremic children identified at KCMC,
9 (27%) were HIV-infected, 1 (%) had NTS and 10 (30%) had S. Ty-
phi bloodstream infection. Of 52 bacteremic adults identified at
KCMC and MRH, 20 (39%) were HIV-infected, 5 (9.6%) had NTS and
16 (30.8%) had S. Typhi bloodstream infection. In KCMC and MRH,
NTS bacteremia was associated with HIV seropositivity in all age
groups, 6 patients with NTS were HIV infected, but not with S.Typhi
bacteremia. In TDH, NTS infection was also associated with HIV-
positivity (OR 1.3, p=0.059) but none of the 9 S. Typhi infections
occurred in an HIV-positive child.
Conclusions: The relative importance of S. Typhi and of NTS as
causes of bloodstream infection among febrile, hospitalized pa-
tients varies considerable between two sites in northern Tanzania.
NTS but not S.Typhi bloodstream infection is strongly associated
with HIV infection. Understanding burden of invasive NTS and S. Ty-
phi in Africa requires an approach that addresses considerable epi-
demiologic heterogeneity and that accounts for the influence of
HIV seroprevalence.
54
Impact of Antiretroviral Therapy on the Clinical Outcomes
and CD4 Cell Responses in Children at Primary Health Care
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Background: Pediatric antiretroviral therapy is provided in all pri-
mary health care facilities in Cameroon. Despite scale-up of these
perinatal prevention efforts, many children still become infected
with the human immunodeficiency virus (HIV). This study assessed
the impact of antiretroviral therapy (ART) on the clinical and im-
munologic outcomes of children in Cameroon.
